4 June 2026
The effectiveness of REAC® technology in managing depression, anxiety and stress: Evidence from DASS-42
Treatments of neurobiological modulation REAC-NPO and REAC-NPPO in the management of anxiety, depression and stress.
News
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
4 June 2026
Treatments of neurobiological modulation REAC-NPO and REAC-NPPO in the management of anxiety, depression and stress.
6 October 2025
Evidence on technology in children with behavioural disorder presented in the framework of the new European guide.
Reserved access
Access to the display of medical devices and information material is reserved for operators in the sector, in compliance with current legislation.
Continuing the navigation I declare to be a professional health worker.
EnterFor information on treatments you can contact the Rinaldi Fontani Institute in Florence.
Go to irf.itLegislative Decree No 46 of 24 February 1997 — Article 21